Vanguard Group
TMCI icon

Vanguard Group’s Treace Medical Concepts TMCI Stock Holding History

Vanguard Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.57M Sell
2,273,094
-458,386
-17% -$1.99M ﹤0.01% 3210
2025
Q3 		$18.3M Buy
2,731,480
+6,240
+0.2% +$40.7K ﹤0.01% 2663
2025
Q2 		$16M Buy
2,725,240
+20,217
+0.7% +$132K ﹤0.01% 2658
2025
Q1 		$22.7M Sell
2,705,023
-27,562
-1% -$248K ﹤0.01% 2451
2024
Q4 		$20.3M Sell
2,732,585
-8,903
-0.3% -$59.6K ﹤0.01% 2575
2024
Q3 		$15.9M Sell
2,741,488
-883,406
-24% -$5.67M ﹤0.01% 2715
2024
Q2 		$24.1M Sell
3,624,894
-678,505
-16% -$5.48M ﹤0.01% 2473
2024
Q1 		$56.2M Buy
4,303,399
+9,610
+0.2% +$128K ﹤0.01% 2119
2023
Q4 		$54.7M Buy
4,293,789
+104,207
+2% +$1.05M ﹤0.01% 2152
2023
Q3 		$54.9M Buy
4,189,582
+155,835
+4% +$2.85M ﹤0.01% 2085
2023
Q2 		$103M Buy
4,033,747
+183,702
+5% +$4.74M ﹤0.01% 1832
2023
Q1 		$97M Buy
3,850,045
+573,196
+17% +$13.5M ﹤0.01% 1848
2022
Q4 		$75.3M Buy
3,276,849
+57,847
+2% +$1.33M ﹤0.01% 1958
2022
Q3 		$71M Buy
3,219,002
+284,961
+10% +$5.51M ﹤0.01% 2002
2022
Q2 		$42.1M Buy
2,934,041
+563,659
+24% +$9.5M ﹤0.01% 2274
2022
Q1 		$44.8M Buy
2,370,382
+94,603
+4% +$1.84M ﹤0.01% 2364
2021
Q4 		$42.4M Buy
2,275,779
+734,203
+48% +$15.2M ﹤0.01% 2451
2021
Q3 		$41.5M Buy
1,541,576
+585,416
+61% +$16.1M ﹤0.01% 2460
2021
Q2 		$29.9M Buy
+956,160
New +$30.4M ﹤0.01% 2633

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group's TMCI Position: Q4 2025 in Review

Vanguard Group reduced its Treace Medical Concepts (TMCI) stake by 17% in Q4 2025, selling an estimated $1.99M and leaving 2,273,094 shares worth $5.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

Vanguard Group first reported a position in TMCI in Q2 2021 and has held it in 19 quarters since. The position peaked at $103M in Q2 2023. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Vanguard Group held 2,273,094 shares of Treace Medical Concepts worth $5.57M as of Q4 2025.
  • Vanguard Group sold 458,386 Treace Medical Concepts shares in Q4 2025, an estimated $1.99M.
  • Treace Medical Concepts made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3210 holding.
  • Vanguard Group first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's Treace Medical Concepts position peaked at $103M in Q2 2023.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.